27 Sep Did the FDA Just Approve Psychedelic Therapy?
If you saw news about an FDA hearing on psychedelic therapy and thought, “Wait, is this happening now?” you’re asking the right question.
The FDA held a public hearing on September 14, 2026, to hear perspectives on the potential future therapeutic use of psychedelic drug products in supervised settings. It was a discussion about what researchers and regulators need to consider. It was not an approval of psilocybin or any other psychedelic treatment.
That distinction can get lost in a headline. A drug being studied, discussed at a hearing, and approved for medical use are three different things.
Our friends at Learn Euphoria broke down what the hearing covered, why supervision and research matter, and what to watch for next. If you’re curious about where psychedelic therapy may be headed, read the full article on Learn Euphoria.
At Chillum, we’re always in favor of learning what’s actually happening before the internet turns a public hearing into a miracle cure announcement.
This post is for educational purposes and does not offer medical advice or claim that any Chillum product treats a medical condition.
No Comments